Drugs News and Research

RSS
Blood pressure drug shows potential as lung cancer treatment

Blood pressure drug shows potential as lung cancer treatment

15,595 meningitis cases this season in Africa

15,595 meningitis cases this season in Africa

Trial of new therapy for pancreatic cancer

Trial of new therapy for pancreatic cancer

Clinical trial of a medication to treat kleptomania

Clinical trial of a medication to treat kleptomania

Discovery of new cell involved with cancer

Discovery of new cell involved with cancer

Sedative-hypnotic drugs to get stronger warning labels

Sedative-hypnotic drugs to get stronger warning labels

Tykerb (lapatinib) - new anti-cancer treatment approved

Tykerb (lapatinib) - new anti-cancer treatment approved

Crocodiles provide clues to new pain treatments for humans

Crocodiles provide clues to new pain treatments for humans

Talk therapy works for panic disorder

Talk therapy works for panic disorder

Two novel therapies for multiple myeloma

Two novel therapies for multiple myeloma

Using a light hand to treat Hodgkin disease

Using a light hand to treat Hodgkin disease

Clinical and imaging evidence of Zolpidem effect in hypoxic encephalopathy

Clinical and imaging evidence of Zolpidem effect in hypoxic encephalopathy

Addiction to sunbathing

Addiction to sunbathing

Guide to minimize microbial food safety hazards of fresh-cut fruits and vegetables

Guide to minimize microbial food safety hazards of fresh-cut fruits and vegetables

$20 million boosts AIDS treatment, vaccine research in Rochester

$20 million boosts AIDS treatment, vaccine research in Rochester

New guidelines on cultivating Artemisia plant used in anti-malaria medicines

New guidelines on cultivating Artemisia plant used in anti-malaria medicines

Antifungal drug kills tuberculosis bug

Antifungal drug kills tuberculosis bug

Stem cells delay neurodegeneration in the brain

Stem cells delay neurodegeneration in the brain

FDA strengthens safety information for Erythropoiesis-Stimulating Agents (ESAs)

FDA strengthens safety information for Erythropoiesis-Stimulating Agents (ESAs)

CMS investigates allegations that Humana encouraged its highest-cost beneficiaries to join competing Medicare prescription drug plan

CMS investigates allegations that Humana encouraged its highest-cost beneficiaries to join competing Medicare prescription drug plan

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.